25 - Express Scripts Holding

Courtesy of Express Scripts Holding

In 2017, pharmacy benefits giant Express Scripts saw its net income skyrocket by 33% year-over-year to $4.51 billion. But a healthy chunk of that income — $1.38 billion — was attributable to the tax law signed by President Donald Trump late last year. While Scripts touted investments in its workforce as a result of the corporate tax cut, it also repurchased 45.9 million of its shares in a stock buyback of nearly $2.95 billion. In 2018, the company will be sure to keep an eye on potential pushback on benefits managers at large, which some critics say contribute to high drug prices because of the industry’s convoluted drug rebate structure. Express Scripts is also in the midst of a proposed $54 billion megadeal to be purchased by insurer Cigna.

Key Metrics & Financials (Last Fiscal Year)

Previous Rank22
Revenues ($M)$100065
Revenue Percent Change-0.2%
Profits ($M)$4517.4
Profits Percent Change32.7%
Assets ($M)$54256
Market Value — as of March 29, 2018 ($M)$38791

More from FORTUNE

Company Facts

SectorHealth Care
IndustryHealth Care: Pharmacy and Other Services
HQ LocationSt. Louis
CEOTimothy C. Wentworth
CEO Title-
Years on Fortune 500 List19

See Full List


More from FORTUNE